Phase I study of accelerated FEC with granulocyte colony-stimulating factor (Lenograstim) support.

With the aim of increasing the dose intensity of chemotherapy in breast cancer, 14 patients with stage II-IV breast cancer were treated with FEC chemotherapy at 2 week intervals together with granulocyte colony-stimulating factor (G-CSF) 5 micrograms kg-1 s.c. on days 2-14. Five of six patients comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Bissett, D., Jodrell, D., Harnett, A. N., Habeshaw, T., Kaye, S. B., Evans, D., Williams, M., Canney, P. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033830/
https://www.ncbi.nlm.nih.gov/pubmed/7540038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033830/
https://www.ncbi.nlm.nih.gov/pubmed/7540038

Ejemplares similares